NAD+, Nicotinamide adenine dinucleotide (30 doses / 125mg per dose), High-stability liposomes, Liquid drops, Instant absorption, Island punch flavour.
Why choose HINNAO NAD+
Until Now stable NAD+ has only been available in IV drip therapy clinics, due to the fragility of the molecule. Using clinically proven high-stability liposomes, as a delivery mechanism HINNAO NAD+ absorbs instantly via the mucous membrane crossing the blood brain barrier.
Low NAD+ levels are associated with ageing and being more prone to chronic diseases such as diabetes, heart disease, Alzheimer’s disease and vision loss.
Absorption in Seconds - The Science
Our patented HINNAO technology stabilises each lipid particle, encapsulating the active ingredient within a phospholipid-based MCT carrier system, protecting it from oxidation. This formulation is designed for rapid absorption through the mucous membrane, allowing the active ingredient to bypass first-pass metabolism in the liver and avoid degradation in the stomach.
NAD+, Nicotinamide adenine dinucleotide (30 doses / 125mg per dose), High-stability liposomes, Liquid drops, Instant absorption, Island punch flavour.
Why choose HINNAO NAD+
Until Now stable NAD+ has only been available in IV drip therapy clinics, due to the fragility of the molecule. Using clinically proven high-stability liposomes, as a delivery mechanism HINNAO NAD+ absorbs instantly via the mucous membrane crossing the blood brain barrier.
Low NAD+ levels are associated with ageing and being more prone to chronic diseases such as diabetes, heart disease, Alzheimer’s disease and vision loss.
Absorption in Seconds - The Science
Our patented HINNAO technology stabilises each lipid particle, encapsulating the active ingredient within a phospholipid-based MCT carrier system, protecting it from oxidation. This formulation is designed for rapid absorption through the mucous membrane, allowing the active ingredient to bypass first-pass metabolism in the liver and avoid degradation in the stomach.
